McLaughlin leads research on identifying minimally invasive biomarkers for MS (News)

McLaughlin leads research on identifying minimally invasive biomarkers for MS

Penn State News
10 April 2018
https://news.psu.edu/story/515260/2018/04/10/research/mclaughlin-leads-research-identifying-minimally-invasive-biomarkers

A study at Penn State College of Medicine may show a new way to monitor the progression and treatment of multiple sclerosis (MS). It showed new, less invasive biomarkers ­— statistical indicators used to measure the presence and severity of a disease. Experimental Biology and Medicine published an article about the study in its Jan. 7 issue (see https://pubmed.ncbi.nlm.nih.gov/29307283/​​​​​​​).